Literature DB >> 25755599

Surgical management of portal cavernoma cholangiopathy.

Vibha Varma1, Arunanshu Behera2, Leileshwar Kaman2, Somnath Chattopadhyay1, Samiran Nundy1.   

Abstract

The majority of patients with portal cavernoma cholangiopathy (PCC) are asymptomatic, however some (5-38%) present with obstructive jaundice, cholangitis, or even biliary pain due to bile duct stones which form as a result of stasis. Most patients with extrahepatic portal venous obstruction (EHPVO) present with variceal bleeding and hypersplenism and these are the usual indications for surgery. Those who present with PCC may also need decompression of their portosystemic system to reverse the biliary obstruction. It is important to realize that though endoscopic drainage has been proposed as a non-surgical approach to the management of PCC it is successful in only certain specific situations like those with bile duct calculi, cholangitis, etc. A small proportion of such patients will continue to have biliary obstruction and these patients are thought to have a mechanical ischemic stricture. These patients will require a second stage procedure in the form of a bilioenteric bypass to reverse the symptoms related to PCC. In the absence of a shuntable vein splenectomy and devascularization may resolve the PCC in a subset of patients by decreasing the portal pressure.

Entities:  

Keywords:  CBD, common bile duct; EHBRD, extrahepatic biliary radical dilatation; EHPVO, extrahepatic portal venous obstruction; ERCP, endoscopic retrograde cholangiopancreatography; GB, gall bladder; HJ, hepaticojejunostomy; IHBRD, intrahepatic biliary radical dilatation; LFT, liver function tests; NCPF, non cirrhotic portal fibrosis; NPSS, non-portosystemic shunt; PB, portal biliopathy; PCC, portal cavernoma cholangiopathy; PSS, portosystemic shunt; PTBD, percutaneous transhepatic biliary drainage; UGI, upper gastrointestinal; biliary obstruction; extrahepatic portal venous obstruction; portal cavernoma cholangiopathy; portal hypertension; portosystemic shunt surgery

Year:  2013        PMID: 25755599      PMCID: PMC4244827          DOI: 10.1016/j.jceh.2013.07.005

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  31 in total

Review 1.  Portal biliopathy.

Authors:  R Chandra; D Kapoor; A Tharakan; A Chaudhary; S K Sarin
Journal:  J Gastroenterol Hepatol       Date:  2001-10       Impact factor: 4.029

2.  Portal biliopathy treated by liver transplantation.

Authors:  Franco Filipponi; Lucio Urbani; Gabriele Catalano; Giuseppe Iaria; Gianni Biancofiore; Roberto Cioni; Alessandro Campatelli; Franco Mosca; Daniela Campani; Paolo Romagnoli
Journal:  Transplantation       Date:  2004-01-27       Impact factor: 4.939

3.  Which treatment to choose for portal biliopathy with extensive portal thrombosis?

Authors:  Antoine Camerlo; Regis Fara; Louise Barbier; Emilie Grégoire; Yves Patrice Le Treut
Journal:  Dig Surg       Date:  2010-10-13       Impact factor: 2.588

Review 4.  Portal hypertensive biliopathy.

Authors:  Radha K Dhiman; Arunanshu Behera; Yogesh K Chawla; Jang B Dilawari; Sudha Suri
Journal:  Gut       Date:  2006-12-14       Impact factor: 23.059

5.  Therapeutic strategies in symptomatic portal biliopathy.

Authors:  Eric Vibert; Daniel Azoulay; Thomas Aloia; Gérard Pascal; Luc-Antoine Veilhan; René Adam; Didier Samuel; Denis Castaing
Journal:  Ann Surg       Date:  2007-07       Impact factor: 12.969

6.  Common bile duct obstruction by portal cavernoma.

Authors:  G Choudhuri; R K Tandon; S Nundy; N K Misra
Journal:  Dig Dis Sci       Date:  1988-12       Impact factor: 3.199

Review 7.  Management of extra hepatic portal venous obstruction (EHPVO): current strategies.

Authors:  Ujjal Poddar; Vibhor Borkar
Journal:  Trop Gastroenterol       Date:  2011 Apr-Jun

Review 8.  [Portal cavernoma compressing the bile duct. Apropos of three cases].

Authors:  H Bejanin; R Baumann; A Choury; J Fritsch; C Buffet
Journal:  Gastroenterol Clin Biol       Date:  1993

9.  Endoscopic sclerotherapy in children: experience with 257 cases of extrahepatic portal venous obstruction.

Authors:  Ujjal Poddar; Babu R Thapa; Kartar Singh
Journal:  Gastrointest Endosc       Date:  2003-05       Impact factor: 9.427

10.  Pseudosclerosing cholangitis in extrahepatic portal venous obstruction.

Authors:  J B Dilawari; Y K Chawla
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

View more
  4 in total

1.  Hepatobiliary quiz-10 (2014).

Authors:  Swastik Agrawal; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2014-06

Review 2.  Portal cavernoma cholangiopathy: consensus statement of a working party of the Indian national association for study of the liver.

Authors:  Radha K Dhiman; Vivek A Saraswat; Dominique C Valla; Yogesh Chawla; Arunanshu Behera; Vibha Varma; Swastik Agarwal; Ajay Duseja; Pankaj Puri; Naveen Kalra; Chittapuram S Rameshbabu; Vikram Bhatia; Malay Sharma; Manoj Kumar; Subhash Gupta; Sunil Taneja; Leileshwar Kaman; Showkat A Zargar; Samiran Nundy; Shivaram P Singh; Subrat K Acharya; Jang B Dilawari
Journal:  J Clin Exp Hepatol       Date:  2014-02-25

3.  Safety of supramesocolic surgery in patients with portal cavernoma without portal vein decompression. Large single centre experience.

Authors:  Safi Dokmak; Béatrice Aussilhou; Alain Sauvanet; Philippe Lévy; Aurélie Plessier; Fadhel S Ftériche; Olivier Farges; Valérie Vilgrain; Dominique C Valla; Jacques Belghiti
Journal:  HPB (Oxford)       Date:  2016-06-16       Impact factor: 3.647

Review 4.  Portal biliopathy.

Authors:  Mohammad S Khuroo; Ajaz A Rather; Naira S Khuroo; Mehnaaz S Khuroo
Journal:  World J Gastroenterol       Date:  2016-09-21       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.